← Back to Market Intelligence/Editorial detail
Market Intelligence / EDITORIAL DETAIL

Electronic Skin Patch Market Report 2024 - 2029 [290 Pages & 177 Tables] Market Outlook:…

Electronic Skin Patch Market Report 2024 - 2029 [290 Pages & 177 Tables] Market is entering a new expansion phase, with public market data placing the opportunity at USD 15 billion in 2024 with a stated CAGR of 12.5%. The Electronic Skin Patch market.

RoboInd market brief: Electronic Skin Patch Market Report 2024 - 2029 [290 Pages & 177 Tables] Market is entering a new expansion phase, with public market data placing the opportunity at USD 15 billion in 2024 with a stated CAGR of 12.5%. The Electronic Skin Patch market.

Market snapshot

  • USD 15 billion in 2024
  • USD 27 billion in 2029

The stated growth rate is 12.5% CAGR for the published forecast window (2024–2029).

What is changing

The Electronic Skin Patch market size is expected to grow from USD 15.0 billion in 2024 to USD 27.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% during the forecast period.The key players Abbott (US), Dexcom, Inc. (US), Medtronic (Ireland), Insulet Corporation (US), Boston Scientific Corporation (US), Koninklijke Philips N.V. (Netherlands), Biolinq Incorporated (US), Zio By iRhythm Technologies, Inc. (US), GENTAG, Inc. (US), VitalConnect (US), The Surgical Company (Netherlands), Senseonics.

Key market signals include Surging demand for remote health monitoring solutions.; Data privacy and security issues; Rising emphasis on improving accuracy of health monitoring patches.

Regional direction

title_en: Global Electronic Skin Patch Market Ecosystem Analysis; body_en: The ecosystem players in the electronic skin patch market involve identifying various categories of companies, organizations, and entities that play essential roles in developing, manufacturing, distributing, and utilizing electronic skin patches. Here are the key ecosystem categories in the electronic skin patch market

Competitive landscape

Public market coverage identifies participants including Abbott, Dexcom Inc, Medtronic, Insulet Corporation, Boston Scientific Corporation, Koninklijke Philips N.V, Biolinq Incorporated, Zio By iRhythm Technologies Inc, GENTAG Inc, VitalConnect. These names indicate activity across the value chain and should not be read as a uniform ranking.

Market outlook

Growth will depend on the conversion of technical capability into repeatable deployments, measurable productivity gains and maintainable operating economics. Buyers are likely to weigh integration, workforce readiness, interoperability and lifecycle support alongside equipment performance.

Market reading: Figures are presented within their stated market definition and forecast window. They should not be combined with figures from other definitions without normalization.

RoboInd editorial channelResearch, robotics companies and market intelligence for cross-border sourcing.Explore the channel ↗
Share this
← Previous postDrone Sensor Market Report 2024 - 2029 [241 Pages & 199 Tables] Market Outlook: US...2026-10-11 Next post →Industrial Control & Factory Automation Market Outlook: USD 435.24 billion in 20302026-10-11
End of editorialExplore more from Market Intelligence ↗